These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25733957)

  • 1. Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies.
    Thase ME
    Dialogues Clin Neurosci; 2014 Dec; 16(4):539-44. PubMed ID: 25733957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.
    Leuchter AF; Hunter AM; Krantz DE; Cook IA
    Dialogues Clin Neurosci; 2014 Dec; 16(4):525-37. PubMed ID: 25733956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological Rhythms Advance in Depressive Disorder.
    Hong W; Zhang Q
    Adv Exp Med Biol; 2019; 1180():117-133. PubMed ID: 31784960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.
    Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH;
    BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.
    Kessler RC; van Loo HM; Wardenaar KJ; Bossarte RM; Brenner LA; Ebert DD; de Jonge P; Nierenberg AA; Rosellini AJ; Sampson NA; Schoevers RA; Wilcox MA; Zaslavsky AM
    Epidemiol Psychiatr Sci; 2017 Feb; 26(1):22-36. PubMed ID: 26810628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.
    Dunlop BW; Rajendra JK; Craighead WE; Kelley ME; McGrath CL; Choi KS; Kinkead B; Nemeroff CB; Mayberg HS
    Am J Psychiatry; 2017 Jun; 174(6):533-545. PubMed ID: 28335622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder.
    Fonseka TM; MacQueen GM; Kennedy SH
    J Affect Disord; 2018 Jun; 233():21-35. PubMed ID: 29150145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.
    Caudill MM; Hunter AM; Cook IA; Leuchter AF
    Clin EEG Neurosci; 2015 Oct; 46(4):277-84. PubMed ID: 25258429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review.
    Dunlop K; Talishinsky A; Liston C
    Curr Psychiatry Rep; 2019 Aug; 21(9):87. PubMed ID: 31410661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.
    Schmidt HD; Shelton RC; Duman RS
    Neuropsychopharmacology; 2011 Nov; 36(12):2375-94. PubMed ID: 21814182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
    Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
    J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood biomarkers and treatment response in major depression.
    Mora C; Zonca V; Riva MA; Cattaneo A
    Expert Rev Mol Diagn; 2018 Jun; 18(6):513-529. PubMed ID: 29701114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A history of early life parental loss or separation is associated with successful cognitive-behavioral therapy in major depressive disorder.
    Niciu MJ; Abdallah CG; Fenton LR; Fasula MK; Black A; Anderson GM; Sanacora G
    J Affect Disord; 2015 Nov; 187():241-4. PubMed ID: 26363143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major depression and its treatment: microRNAs as peripheral biomarkers of diagnosis and treatment response.
    Lopez JP; Kos A; Turecki G
    Curr Opin Psychiatry; 2018 Jan; 31(1):7-16. PubMed ID: 29076893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric major depressive disorder: neurobiology and implications for early intervention.
    Cullen K; Klimes-Dougan B; Kumra S; Schulz SC
    Early Interv Psychiatry; 2009 Aug; 3(3):178-88. PubMed ID: 22640381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
    Cook IA; Hunter AM; Gilmer WS; Iosifescu DV; Zisook S; Burgoyne KS; Howland RH; Trivedi MH; Jain R; Greenwald S; Leuchter AF
    J Clin Psychiatry; 2013 Jan; 74(1):51-6. PubMed ID: 23419226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene × environment interactions in the prediction of response to antidepressant treatment.
    Klengel T; Binder EB
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):701-11. PubMed ID: 23237009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.
    Grosse L; Carvalho LA; Birkenhager TK; Hoogendijk WJ; Kushner SA; Drexhage HA; Bergink V
    Psychopharmacology (Berl); 2016 May; 233(9):1679-88. PubMed ID: 25953327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.